解开甲状腺毒性周期性的临床复杂性:一个案例报告
Gowri Renganathan1, Sudhagar Thangarasu1, Baljinder Singh2
1Internal Medicine, Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine, El Paso, USA.
Cureus
|September 5, 2024
概括
甲状腺毒性周期性 (TPP) 呈现出低血和肌肉,经常模仿其他疾病. 这一案例凸显了甲状腺功能障碍是重复性发作的关键,但微妙的原因.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 甲状腺毒性周期性 (TPP) 是一种罕见的病症,其特征是低血,肌肉和甲状腺功能障碍.
- 由于患病率低且症状与其他神经肌肉疾病重叠,诊断可能具有挑战性.
研究的目的:
- 强调认识到甲状腺功能障碍症是导致经常性肌肉的原因的重要性.
- 为了说明与微妙的甲状腺功能过高症状相关的诊断挑战.
- 突出需要在急性软性的情况下进行广泛的差异诊断.
主要方法:
- 一个32岁的男性的病例报告显示,他出现了反复复发的下肢虚弱.
- 临床评估,包括评估甲状腺功能过高的症状 (热不耐受,体重减轻,).
- 实验室调查显示低血和甲状腺功能过高状态 (格雷夫斯病).
主要成果:
- 患者经历了急性双边下肢虚弱和无法行走的情况.
- 由于格雷夫斯病的低血压和甲状腺功能过高症得到证实.
- 在补治疗和开始服用甲基马和醇后,症状有所改善.
结论:
- 内分泌和代谢障碍是急性性的差分诊断中的关键因素.
- 微妙的甲状腺功能过高症状可以掩盖TPP,使诊断复杂化.
- 快速识别和治疗甲状腺功能障碍对于解决TPP发作至关重要.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
705
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
705
Acute Pancreatitis II: Clinical Manifestations and Management
111
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
111
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K


